|
EP0921196A1
(en)
*
|
1997-12-02 |
1999-06-09 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
EP0922765B1
(en)
*
|
1997-12-02 |
2005-11-23 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
US20040009486A1
(en)
*
|
1999-10-29 |
2004-01-15 |
Sorge Joseph A. |
Compositions and methods utilizing DNA polymerases
|
|
US20030228616A1
(en)
*
|
1999-10-29 |
2003-12-11 |
Stratagene |
DNA polymerase mutants with reverse transcriptase activity
|
|
US20050123940A1
(en)
*
|
1999-10-29 |
2005-06-09 |
Stratagene California |
Compositions and methods for synthesizing cDNA
|
|
EP1452593B1
(en)
*
|
2001-11-14 |
2009-04-08 |
Toyo Boseki Kabushiki Kaisha |
Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
|
|
AU2004230569B2
(en)
|
2003-03-31 |
2007-12-06 |
F. Hoffmann-La Roche Ag |
Compositions and methods for detecting certain flaviviruses, including members of the Japanese encephalitis virus serogroup
|
|
US20050208482A1
(en)
|
2004-03-16 |
2005-09-22 |
Cohen David I |
Tat-based immunomodulatory compositions and methods for their discovery and use
|
|
US8962293B2
(en)
|
2006-10-18 |
2015-02-24 |
Roche Molecular Systems, Inc. |
DNA polymerases and related methods
|
|
JP5692933B2
(ja)
|
2009-03-23 |
2015-04-01 |
ナニアールエックス セラピューティックス インコーポレイテッド |
免疫刺激ＨＩＶＴａｔ誘導体ポリペプチドによる腫瘍治療
|
|
EP2582803B1
(en)
|
2010-06-18 |
2015-02-25 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
WO2011157436A1
(en)
|
2010-06-18 |
2011-12-22 |
Roche Diagnostics Gmbh |
Dna polymerases with increased 3'-mismatch discrimination
|
|
CN103003418B
(zh)
|
2010-06-18 |
2015-08-26 |
霍夫曼-拉罗奇有限公司 |
具有增强的3’-错配辨别力的dna聚合酶
|
|
ES2536252T3
(es)
|
2010-06-18 |
2015-05-21 |
F. Hoffmann-La Roche Ag |
ADN polimerasas con diferenciación de desapareamientos 3' aumentada
|
|
CN103025869B
(zh)
|
2010-06-18 |
2015-07-01 |
霍夫曼-拉罗奇有限公司 |
具有增强的3’-错配辨别力的dna聚合酶
|
|
EP2582806B1
(en)
|
2010-06-18 |
2015-12-16 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
WO2011157434A1
(en)
|
2010-06-18 |
2011-12-22 |
Roche Diagnostics Gmbh |
Dna polymerases with increased 3'-mismatch discrimination
|
|
ES2564692T3
(es)
|
2010-06-18 |
2016-03-28 |
F. Hoffmann-La Roche Ag |
ADN polimerasas con discriminación incrementada de no correspondencia 3'
|
|
EP2675897B1
(en)
|
2011-02-15 |
2016-05-11 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
ES2561885T3
(es)
|
2011-04-11 |
2016-03-01 |
F. Hoffmann-La Roche Ag |
ADN polimerasas de actividad mejorada
|
|
CA2839964C
(en)
|
2011-07-28 |
2019-03-12 |
F. Hoffmann-La Roche Ag |
Dna polymerases with improved activity
|
|
JP6144697B2
(ja)
|
2011-12-08 |
2017-06-07 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
改善された活性を有するｄｎａポリメラーゼ
|
|
EP2788480B1
(en)
|
2011-12-08 |
2019-01-16 |
Roche Diagnostics GmbH |
Dna polymerases with improved activity
|
|
WO2013083263A1
(en)
|
2011-12-08 |
2013-06-13 |
Roche Diagnostics Gmbh |
Dna polymerases with improved activity
|
|
WO2015051245A1
(en)
|
2013-10-04 |
2015-04-09 |
Pin Pharma, Inc. |
Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment
|
|
ES2969883T3
(es)
|
2018-03-21 |
2024-05-23 |
Hoffmann La Roche |
ADN polimerasas para la incorporación eficiente y eficaz de dNTP metilados
|
|
JP7504872B2
(ja)
|
2018-09-13 |
2024-06-24 |
エフ． ホフマン－ラ ロシュ アーゲー |
改善されたストランド置換能力を有する変異体ｄｎａポリメラーゼ
|
|
CN111733145A
(zh)
*
|
2020-07-01 |
2020-10-02 |
济南国科医工科技发展有限公司 |
重组酶的纯化方法
|
|
WO2026153862A1
(en)
|
2025-01-14 |
2026-07-23 |
F. Hoffmann-La Roche Ag |
Dna polymerases with improved activity
|